Editorial Board Member

Ingolf Cascorbi
Institute of Experimental and Clinical Pharmacology, Kiel University, Kiel, Germany.
HomePage
Research Interests
cancer biology, pharmacokinetics, genotyping, mutation, DNA, genetics, enzymes, drug safety, pharmaceutical development, intensive care medicine.
Contributions:

Germline variants in cancer therapy

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/